Free Lesson Preview
This is just the beginning
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Clinical Research Coordinator
Full course Β· Safety Reporting and Pharmacovigilance for CRCs
Free Lesson Preview
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Navigate dual reporting obligations to sponsor and IRB with different timelines, forms, and information requirements.
A participant in an anticoagulant trial presents to the emergency department with gastrointestinal bleeding. The investigator assesses the event as a serious adverse event -- hospitalization required -- and determines it is possibly related to the study drug. The coordinator has done this before. The SAE form goes to the sponsor within 24 hours. The clinical narrative describes the bleeding episode, the treatment provided, the participant's current condition. That reporting obligation is clear, practiced, and time-critical.
But there is a second obligation. The same event that triggers sponsor reporting may also trigger a report to the Institutional Review Board. And here is where I have watched even experienced coordinators hesitate -- because the IRB report is not a copy of the SAE form. It uses a different form. It follows a different timeline. It emphasizes different information. And the determination of whether this particular event requires IRB reporting at all depends on institutional policy, not on the sponsor's protocol.
The sponsor wants clinical detail: onset, severity, treatment, outcome, causality. The IRB wants something different. The IRB wants to know whether this event changes the risk-benefit equation for participants at this site, whether it constitutes an unanticipated problem, whether the research should be modified, whether currently enrolled participants need new information. Same event. Different questions. Different recipients. Different deadlines.
This lesson addresses the second stream -- the one that flows to your institution's IRB or ethics committee. If the prior three lessons in this module taught you how to process incoming safety information from the sponsor, this lesson teaches you when and how that information must go back out to the body that approved your research in the first place.
Progress saves itself β finish reading and this lesson completes